Charles J Homcy insider trades
Open-market stock purchases and sales by Charles J Homcy, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since May 19, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 20, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $52.2K |
| Jun 8, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | MAZE Maze Therapeutics, Inc | Sold (not open market) | — |
| Nov 19, 2025 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| Oct 23, 2025 | MAZE Maze Therapeutics, Inc | Sold (not open market) | — |
Companies traded
- BBIO BridgeBio Pharma, Inc: 10 sales, last Jun 22, 2026
- MAZE Maze Therapeutics, Inc: other filings, last Jun 8, 2026
- PLRX Pliant Therapeutics, Inc: other filings, last Jun 29, 2021
- PHIC Population Health Investment Co, Inc: other filings, last Jan 26, 2021
- PTLA Portola Pharmaceuticals Inc: 17 sales, last Mar 28, 2019
- GBT Global Blood Therapeutics, Inc: 9 sales, last Jun 20, 2018
- MYOK MyoKardia Inc: other filings, last Nov 29, 2016
- CEPH Cephalon Inc: other filings, last Oct 14, 2011
- GERN Geron Corp: other filings, last May 11, 2011